November 12, 2018
November 12, 2018 —
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying weather patterns and geographical distributions of patients in San Diego, the research team determined that this inflammatory disease likely has multiple environmental triggers influenced by a combination of temperature, precipitation and wind patterns.
November 2, 2018
November 2, 2018 —
UC San Diego Health has been named “HealthCare’s Most Wired” by the College of Healthcare Information Management Executives (CHIME). The mission of the CHIME HealthCare’s Most Wired program is to elevate the health and health care of communities around the world through the optimal use of information technology.
November 1, 2018
November 1, 2018 —
Researchers at University of California San Diego School of Medicine and Kaiser Permanente have discovered that mothers who breastfed a child or children for six months or more are at lower risk for developing non-alcoholic fatty liver disease (NAFLD) years later during mid-life. With no other current prevention options aside from a healthy lifestyle, they say the finding may represent an early modifiable risk factor for a serious and chronic disease.
October 25, 2018
October 25, 2018 —
Researchers have trained a machine learning algorithm to identify and predict which genes make infectious bacteria resistant to antibiotics. The approach was tested on strains of Mycobacterium tuberculosis—the bacteria that cause tuberculosis (TB) in humans. It identified 33 known and 24 new antibiotic resistance genes in these bacteria. The approach could be used to predict resistance in other infection-causing pathogens.
October 24, 2018
October 24, 2018 —
The mechanism leading to development of type 1 diabetes remains a mystery, hampering the ability to find new ways to prevent, treat or even cure this condition. With a new $3.3 million grant, University of California School of Medicine researchers hope to create a high resolution reference map of pancreatic cells that will identify molecular changes that arise during type 1 diabetes.
October 22, 2018
October 22, 2018 —
Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself. Instead, any negative changes to clinical results are more likely due to decreased blood flow.
October 18, 2018
October 18, 2018 —
Steffanie Strathdee, PhD, associate dean of global health sciences at University of California San Diego School of Medicine, was named today one of TIME magazine’s 50 Most Influential People in Health Care for 2018, which identifies people who “have changed the state of health care in America this year, and bear watching for what they do next.”
October 16, 2018
October 16, 2018 —
Researchers from University of California San Diego School of Medicine, with statewide collaborators, report that patients who recorded videos of themselves taking tuberculosis (TB) medications better adhered to treatment than patients who were observed in-person.
October 15, 2018
October 15, 2018 —
Lucila Ohno-Machado, MD, PhD, chair of the Department of Biomedical Informatics at UC San Diego Health, professor of medicine and associate dean for informatics and technology at the School of Medicine, and a founding faculty member of UC San Diego Halicioğlu Data Science Institute, has been elected to the National Academy of Medicine (NAM).
October 12, 2018
October 12, 2018 —
Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.
